-+ 0.00%
-+ 0.00%
-+ 0.00%
Intrasense wins CE mark for DUOnco Unity cancer CT follow-up AI tool
Share
Listen to the news
Intrasense wins CE mark for DUOnco Unity cancer CT follow-up AI tool
  • Intrasense secured CE marking under EU MDR 2017/745 for DUOnco Unity, an AI tool supporting oncologic CT interpretation.
  • The software automates lesion detection, segmentation, and longitudinal tracking across thorax-abdomen-pelvis scans to standardize response assessment.
  • Development involved Guerbet, Gustave Roussy, and Angers University Hospital, with support from Bpifrance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intrasense SA published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending